Literature DB >> 10755413

Association between high-risk HPV types, HLA DRB1* and DQB1* alleles and cervical cancer in British women.

J Cuzick1, G Terry, L Ho, J Monaghan, A Lopes, P Clarkson, I Duncan.   

Abstract

Cervical scrapes from 116 British women referred with cervical cancer were tested for the presence of high oncogenic risk human papillomavirus (HPV) genotypes (HPV(hr)). Ninety-four per cent of the scrapes had one or more of these virus types and 66% were HPV16-positive. HPV18 was more frequent in adenocarcinoma. No evidence was found for an increased cancer risk associated with the HPV16 E6 350G variant. The HLA DRB1* and DQB1* alleles in these women and in 155 women with normal cytology and negative for HPV(hr) DNA were compared. DQB1*0301 alone (2P = 0.02) and in combination with DRB1*0401 (2P = 0.02) was found to be associated with cervical cancer. This was more marked in cancers positive for HPV types other than HPV16. In contrast, DRB1*1501 alone and in combination with DQB1*0602 was not significantly elevated in cancers overall, but did show some excess in HPV16-positive cancers (2P = 0.05), associated with HPV16-positive cervical cancers. Taking all cancers together, a marginally significant protective effect was found for DQB1*0501 (2P = 0.03) but no protective effect could be seen for DRB1*1301.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755413      PMCID: PMC2374489          DOI: 10.1054/bjoc.1999.1103

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

1.  HLA antigens and cervical carcinoma.

Authors:  R Wank; D J Schendel; C Thomssen
Journal:  Nature       Date:  1992-03-05       Impact factor: 49.962

2.  Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities.

Authors:  P Londesborough; L Ho; G Terry; J Cuzick; C Wheeler; A Singer
Journal:  Int J Cancer       Date:  1996-10-21       Impact factor: 7.396

3.  A call to redefine where cancer begins.

Authors:  J Randal
Journal:  J Natl Cancer Inst       Date:  1995-01-18       Impact factor: 13.506

4.  Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles.

Authors:  K Odunsi; G Terry; L Ho; J Bell; J Cuzick; T S Ganesan
Journal:  Int J Cancer       Date:  1996-09-04       Impact factor: 7.396

5.  Different HLA-DR-DQ haplotypes are associated with cervical intraepithelial neoplasia among human papillomavirus type-16 seropositive and seronegative Swedish women.

Authors:  C B Sanjeevi; P Hjelmström; G Hallmans; F Wiklund; P Lenner; T Angström; J Dillner; A Lernmark
Journal:  Int J Cancer       Date:  1996-11-15       Impact factor: 7.396

6.  Persistence of type-specific human papillomavirus infection among cytologically normal women.

Authors:  A Hildesheim; M H Schiffman; P E Gravitt; A G Glass; C E Greer; T Zhang; D R Scott; B B Rush; P Lawler; M E Sherman
Journal:  J Infect Dis       Date:  1994-02       Impact factor: 5.226

7.  Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression.

Authors:  M F Duggan-Keen; P J Keating; F R Stevens; P Sinnott; P J Snijders; J M Walboomers; S Davidson; R D Hunter; P A Dyer; P L Stern
Journal:  Eur J Immunogenet       Date:  1996-08

8.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

9.  Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments.

Authors:  T Yamada; C M Wheeler; A L Halpern; A C Stewart; A Hildesheim; S A Jenison
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  HPV testing in primary screening of older women.

Authors:  J Cuzick; E Beverley; L Ho; G Terry; H Sapper; I Mielzynska; A Lorincz; W K Chan; T Krausz; P Soutter
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

View more
  24 in total

1.  The frequency of HLA alleles in the Romanian population.

Authors:  Ileana Constantinescu; Voicu Boșcaiu; Petru Cianga; Andrei-Antoniu Dinu; Elena Gai; Mihaela Melinte; Ana Moise
Journal:  Immunogenetics       Date:  2015-12-28       Impact factor: 2.846

2.  The correlation between HLA-DRB1 and HLA-DQB1 gene polymorphisms and cytokines in HPV16 infected women with advanced cervical cancer.

Authors:  Yan Liu; Jian Zhang; Zhong-Ming Jia; Ji-Chang Li; Chun-Hua Dong; Yong-Mei Li
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Human leukocyte antigen-DRB1*1501 and DQB1*0602 alleles are cervical cancer protective factors among Uighur and Han people in Xinjiang, China.

Authors:  Jian Ming Hu; Qi Sun; Ling Li; Chun Xia Liu; Yun Zhao Chen; Hong Zou; Li Juan Pang; Jin Zhao; Lan Yang; Yu Wen Cao; Xiao Bin Cui; Yan Qi; Wei Hua Liang; Wen Jie Zhang; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

4.  HLA class-II allele frequencies in Turkish breast cancer patients.

Authors:  Faik Deniz Gun; Ozlem Goruroglu Ozturk; Ayse Polat; Gurbuz Polat
Journal:  Med Oncol       Date:  2011-03-04       Impact factor: 3.064

5.  Classical HLA alleles are associated with prevalent and persistent cervical high-risk HPV infection in African women.

Authors:  Sally N Adebamowo; Adebowale A Adeyemo
Journal:  Hum Immunol       Date:  2019-05-06       Impact factor: 2.850

6.  Correlates of IL-10 and IL-12 concentrations in cervical secretions.

Authors:  Patti E Gravitt; Allan Hildesheim; Rolando Herrero; Mark Schiffman; Mark E Sherman; M Concepcion Bratti; Ana C Rodriguez; Lidia A Morera; Fernando Cardenas; Frederick P Bowman; Keerti V Shah; Peggy A Crowley-Nowick
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

7.  Multi-site study of HPV type-specific prevalence in women with cervical cancer, intraepithelial neoplasia and normal cytology, in England.

Authors:  R Howell-Jones; A Bailey; S Beddows; A Sargent; N de Silva; G Wilson; J Anton; T Nichols; K Soldan; H Kitchener
Journal:  Br J Cancer       Date:  2010-07-13       Impact factor: 7.640

8.  A comprehensive review on host genetic susceptibility to human papillomavirus infection and progression to cervical cancer.

Authors:  Koushik Chattopadhyay
Journal:  Indian J Hum Genet       Date:  2011-09

9.  Translational potential into health care of basic genomic and genetic findings for human immunodeficiency virus, Chlamydia trachomatis, and human papilloma virus.

Authors:  Jelena Malogajski; Ivan Brankovic; Stephan P Verweij; Elena Ambrosino; Michiel A van Agtmael; Angela Brand; Sander Ouburg; Servaas A Morré
Journal:  Biomed Res Int       Date:  2013-05-23       Impact factor: 3.411

10.  Genomic imbalances in 70 snap-frozen cervical squamous intraepithelial lesions: associations with lesion grade, state of the HPV16 E2 gene and clinical outcome.

Authors:  W Alazawi; M Pett; S Strauss; R Moseley; J Gray; M Stanley; N Coleman
Journal:  Br J Cancer       Date:  2004-12-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.